$Novavax (NVAX.US)$ Six American biotechnology analysts have...

雷超 commented on a stock · Sep 4, 2024 22:09

Six American biotechnology analysts have indicated that Novavax is approaching break-even. They forecast that the company will announce its final loss in 2024 and then achieve a profit of $29 million in 2025. Therefore, it is expected that the company will achieve a break-even point in just over a year. In order to reach the break-even point by 2025, the company must grow at what rate per year? According to the analysts' estimates, they expect the company to grow by an average of 76% year-on-year, which suggests that the analysts are confident. If the business growth rate slows down, the time to profitability will be later than expected.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

9472 Views

Comment

雷超

逢买必涨📈

Followers

Following

Visitors